Table 1 Demographics and participant characteristics of discovery and validation cohort.

From: Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance

Discovery cohort

USA

Sri Lanka

Total (n = 294)

Bacterial (n = 42)

Viral (n = 43)

Noninfectious (n = 67)

Bacterial (n = 60)

Viral (n = 82)

Age, median (IQR)

48 (31, 61)

58 (49, 66)

50 (28, 66)

54 (42, 66)

41 (31, 50)

34 (23, 51)

Sex, n (%)

 Male

155 (52.7)

28 (66.7)

14 (32.6)

30 (44.7)

39 (66.7)

38 (51.2)

 Female

139 (47.3)

14 (33.3)

29 (67.4)

37 (55.3)

21 (33.3)

44 (48.8)

Race, n (%)

 Hispanic

142 (48.3)

38 (90.5)

39 (93.0)

65 (97.0)

 Non-Hispanic

4 (1.4)

2 (4.8)

1 (2.3)

1 (1.5)

5 (1.7)

2 (4.7)

2 (4.6)

1 (1.5)

Ethnicity, n (%)

 White

87 (29.5)

27 (64.3)

25 (58.1)

35 (52.2)

 Black

56 (19.0)

13 (31.0)

14 (32.6)

29 (43.3)

 Asian/S. Asian

144 (49.0)

0 (0.0)

0 (0.0)

2 (4.7)

60 (100)

82 (100)

 American In/Alaska Na

5 (1.7)

2 (4.8)

1 (2.3)

2 (3.0)

 Hawaiian/Pacific Is

1 (0.3)

0 (0.0)

1 (2.3)

0 (0.0)

 Other/unknown

1 (0.3)

0 (0.0)

0 (0.0)

1 (1.5)

 Duration ill, median days (IQR)

4 (3, 6)

3 (2, 5.5)

4 (2. 5, 5.5)

3 (2, 11)

5 (3, 8)

4 (3, 5)

 Hospital length of stay, median days (IQR)

4 (2, 6)

6 (3, 9)

0 (0, 15)

2 (1, 6)

5 (4, 6)

4 (3, 6)

 Intensive care, n (%)

26 (8.8)

11 (26.2)

3 (7.0)

11 (16.4)

1 (1.7)

0 (0.0)

 Mech. ventilation, n (%)

14 (4.8)

6 (14.3)

1 (2.3)

6 (9.0)

1 (1.7)

0 (0.0)

 Mortality, n (%)

12 (4.0)

5 (11.9)

0 (0.0)

6 (9.0)

0 (0.0)

1 (1.2)

 Pathogens

11 S. aureus

17 FluA

NA

30 Leptospira spp.

43 Dengue

14 S. pneumo

12 FluB

 

27 Rickettsia spp.

23 FluA

9 E. coli

14 RSV

 

3 C. burnetii

16 FluB

9 K. pneumo

    

Validation cohort

USA

Sri Lanka

Cambodia

Tanzania

Australia

Total (n = 101)

Bacterial (n = 3)

Viral (n = 16)

Bacterial n = 24)

Viral (n = 29)

Bacterial (n = 10)

Bacterial (n = 15)

Viral (n = 4)

Age, median (IQR)

36.5 (27.8, 54.3)

61 (60.5, 73.5)

49 (29, 60)

37 (29.5, 58)

30 (25, 47)

51 (36.3, 58.8)

34 (30.5, 41.5)

27 (27, 35.5)

Sex, n (%)

 Male

55 (54.5)

3 (100)

5 (31.3)

14 (58.3)

21 (72.4)

5 (50.0)

6 (40.0)

1 (25.0)

 Female

46 (45.5)

0 (0.0)

11 (68.8)

10 (41.7)

8 (27.6)

5 (50.0)

9 (60.0)

3 (75.0)

Race, n (%)

 Hispanic

3 (100)

16 (100)

4 (100)

 Non-Hispanic

0 (0.0)

0 (0.0)

0 (0.0)

 Unknown

0 (0.0)

0 (0.0)

0 (0.0)

Ethnicity, n (%)

 White

12 (11.9)

2 (66.7)

6 (37.5)

4 (100)

 Black

26 (25.7)

1 (33.3)

10 (62.5)

15 (100)

0 (0.0)

 Asian/S. Asian

63 (62.4)

0 (0.0)

0 (0.0)

24 (100)

29 (100)

10 (100)

0 (0.0)

 Pathogens

 

1 S. aureus

2 Dengue

15 Leptospira spp.

18 Dengue

10 B. pseudomallei

3 Brucella spp.

4 FluA

1 VGS

4 FluA

9 Rickettsia spp.

7 FluA

 

2 Rickettsia spp.

 

1 P. aerug

2 RSV

 

4 HRV

 

10 C. burnetii

 
 

2 HRV

     
 

3 Paraflu

     
 

3 hMPV

     
  1. Days ill number of days ill prior to presentation, ICU Intensive care unit, Mech. Ventilation Invasive Mechanical Ventilation, NA not applicable, S. aureus Staphylococus aurus, S. pneumo Steptococcus pneumoniae, E. coli Escherichia coli, K. pneumo Klebsiella pneumoniae, FluA Influenza A, FluB Influenza B, RSV Respiratory Syncitial Virus, C. burnetii Coxiella burnetii, VGS Viridians group Streptococcus, P. aerug Pseudomonas aeruginosa, HRV Human Rhinovirus, Paraflu ParaInfluenza, hMPV. human Metapneumovirus, B. pseudomallei Burkholderia pseudomallei.